Efficacy and safety of disodium ascorbyl phytostanol phosphates in men with moderate dyslipidemia

OBJECTIVE: This study investigated the efficacy, safety, tolerability, and pharmacokinetics of a novel cholesterol absorption inhibitor, FM-VP4, comprising disodium ascorbyl sitostanol phosphate (DASP) and disodium ascorbyl campestanol phosphate (DACP). METHODS: In phase 1, 30 men received a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Vissers, Maud N., Trip, Mieke D., Pritchard, P. Haydn, Tam, Patrick, Lukic, Tatjana, de Sain-van der Velden, Monique G., de Barse, Martina, Kastelein, John J. P.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426926/
https://www.ncbi.nlm.nih.gov/pubmed/18320185
http://dx.doi.org/10.1007/s00228-008-0462-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426926/
https://www.ncbi.nlm.nih.gov/pubmed/18320185
http://dx.doi.org/10.1007/s00228-008-0462-1

Ejemplares similares